Linde India (523457) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
9 Feb, 2026Executive summary
Unaudited standalone and consolidated financial results for Q3 and nine months ended 31 December 2025 were approved, with a limited review conducted by statutory auditors.
Appointment of Mr. Ajay Kumar Sah as Interim CFO effective 16 February 2026, bringing 25 years of finance experience across Asia and Africa.
Financial highlights
Standalone revenue from operations for Q3 FY26 was ₹7,010.34 million, up from ₹6,058.57 million in Q3 FY25.
Standalone profit after tax for Q3 FY26 was ₹1,915.90 million, compared to ₹1,139.88 million in Q3 FY25.
Consolidated revenue from operations for Q3 FY26 was ₹7,010.34 million, with consolidated profit after tax at ₹1,933.25 million.
EPS (consolidated, basic and diluted) for Q3 FY26 was ₹22.67, up from ₹13.64 in Q3 FY25.
Expenses for Q2 FY26 and nine months ended December 2025 are net of ₹900 million due to reversal of related liabilities from contractual changes.
Outlook and guidance
Management continues to monitor regulatory and legal proceedings, with uncertainties around their ultimate outcomes and financial impact.
Latest events from Linde India
- Record EBITDA and debt reduction, but divestment drove reported profit amid COVID-19 uncertainty.523457
Q4 2019 - Underlying gases growth and lower interest costs cushioned a pandemic-hit FY2020.523457
Q4 2020 - FY21 rebounded strongly, though reported profit included a major land-sale gain.523457
Q4 2021 - Strong growth, a debt-free balance sheet and a Rs 14,200 million PED order book.523457
Q4 22/23 - Revenue and EBITDA grew, led by Gases, amid unresolved related-party proceedings.523457
Q4 23/24 - Strong revenue growth and segment results, but regulatory proceedings create uncertainty.523457
Q1 26/27 - Strong financial results and dividend, but regulatory/legal uncertainties led to a qualified audit opinion.523457
Q4 25/26 - Q2 FY26 saw strong revenue and profit growth, but regulatory risks remain elevated.523457
Q2 25/26 - Quarterly profit and revenue declined year-over-year amid ongoing SEBI regulatory scrutiny.523457
Q3 24/25